$MMED Q1 '27 Earnings Results & Recap • Reported GAAP EPS of $0.00 • Reported revenue of $829M up 15.78% YoY • For fiscal year 2027 ending April 30, 2027, MiniMed expects organic revenue growth of approximately 10.5%, raised from approximately 10%, and reaffirmed an adjusted EBITDA margin of approximately 16%.